CRISPR and gene editing Knowledge-Based Study

Study notes

1. Biological Origin and Discovery

   CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. Originally discovered in bacteria and archaea, these sequences represent an adaptive immune defense system against invading viral genomes, such as bacteriophages, and foreign plasmids.

   When a bacterium survives a viral infection, it captures short fragments of the viral DNA and integrates them into its own genome as spacers between repetitive palindromic sequences. If the same virus invades again, the bacterium transcribes these spacers into RNA to direct molecular machinery to neutralize the foreign genetic material.

   The Machinery of Targeted Cleavage

   Biotechnologists have adapted the type II CRISPR system from Streptococcus pyogenes for precise gene editing. The engineered system relies on two fundamental elements:

   • Cas9 Endonuclease: An enzyme that acts as molecular scissors capable of cutting both strands of target DNA to generate a double-strand break (DSB).
   • Single Guide RNA (sgRNA): A synthetic molecule combining the targeting specificity of crRNA (CRISPR RNA) and the structural scaffold of tracrRNA (trans-activating crRNA). The sgRNA contains approximately 20 nucleotides designed to be complementary to the target sequence.
   • Protospacer Adjacent Motif (PAM): A short, conserved DNA sequence (5'-NGG-3' for S. pyogenes Cas9) located immediately downstream of the target DNA sequence. Cas9 must recognize the PAM before binding and unwinding the target DNA. Cleavage occurs strictly 3 base pairs upstream of the PAM.

   Cellular Response to Double-Strand Breaks

   Once Cas9 introduces a site-specific double-strand break, the host cell detects the damage and initiates one of two primary endogenous repair pathways:

   1. Non-Homologous End Joining (NHEJ)

   NHEJ directly ligates the broken DNA ends without requiring a homologous template. Because this process is inherently error-prone, it frequently introduces insertions or deletions (indels). These frameshift mutations typically lead to premature stop codons, effectively knocking out gene function.

   2. Homology-Directed Repair (HDR)

   When an exogenous donor DNA template containing flanking homology arms is co-introduced with the CRISPR-Cas9 complex, the cell can repair the lesion via HDR. This precise pathway allows researchers to correct pathogenic mutations or integrate specific new sequences into the genome.

   Significance and Future Horizons

   Compared to earlier genome-editing technologies such as Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs), CRISPR-Cas9 is markedly simpler, more cost-effective, and capable of multiplexing (targeting several genes simultaneously by supplying multiple distinct guide RNAs).

   Major Applications:

   • Therapeutics: Ex vivo and in vivo therapies targeting monogenic disorders, such as sickle cell anemia and beta-thalassemia.
   • Agriculture: Enhancing crop yield, drought tolerance, and resistance to plant pathogens without necessarily introducing foreign transgenes.
   • Functional Genomics: Systematic genome-wide loss-of-function screening to identify disease-related genes and drug targets.

   Challenges and Ethics:

   Key technical hurdles include limiting off-target cleavage (unintended cuts at non-target sites with sequence similarity) and optimizing in vivo delivery vectors. Furthermore, a strict bioethical boundary exists between somatic gene editing (affecting only the treated individual) and germline editing (introducing heritable genetic alterations into embryos or gametes).